Profile
| Role | Insider |
|---|---|
| Notability | 30/100 |
Updated Jul 16, 2026
Saad Mark E has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $7.35M.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-11 | AXSM | Axsome Therapeutics, Inc. | M — Option exercise | 1.4K | — | |
| 2026-01-03 | AXSM | Axsome Therapeutics, Inc. | S — Open-market sale [10b5-1] | 31.3K | $165.18 | $5.18M |
| 2026-01-03 | AXSM | Axsome Therapeutics, Inc. | M — Option exercise [10b5-1] | 31.3K | $4.95 | $155K |
| 2026-01-03 | AXSM | Axsome Therapeutics, Inc. | S — Open-market sale [10b5-1] | 6.2K | $165.18 | $1.03M |
| 2026-01-03 | AXSM | Axsome Therapeutics, Inc. | M — Option exercise [10b5-1] | 6.2K | $8.02 | $50K |
| 2025-09-05 | AXSM | Axsome Therapeutics, Inc. | S — Open-market sale | 9.1K | $125.07 | $1.14M |
| 2025-09-05 | AXSM | Axsome Therapeutics, Inc. | M — Option exercise | 9.1K | $9.00 | $82K |
Saad Mark E is a corporate insider — currently tracked as Insider of Axsome Therapeutics, Inc. (AXSM). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($7.35M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Saad Mark E profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.